Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yifeng Biotechnology
Shanghai, Shanghai, Chinayifengbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai Yifeng Biotechnology is a contract research organization (CRO) based in Shanghai, China, specializing in providing comprehensive technical services for life science research. The company offers a wide range of services including molecular biology, cell biology, protein expression and purification, and antibody production. Located in the Zhangjiang Hi-Tech Park, it serves as a technical partner for universities, research institutes, and pharmaceutical companies in their early-stage discovery and preclinical studies. Their service portfolio includes gene synthesis, stable cell line construction, and animal model development, aimed at accelerating the R&D process for various therapeutic modalities.
- Modalities
- Small moleculeAntibodyProteinCell therapyGene therapyPeptides
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Shanghai Yifeng Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Yifeng Biotechnology.